カテゴリー： GlobalInfoResearch, 世界

化学療法による骨髄抑制治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Chemotherapy-Induced Myelosuppression Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102889）・商品コード：GIR9102889
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月23日（※2024年版があります。お問い合わせください）
・ページ数：121
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、化学療法による骨髄抑制治療の世界市場について調べ、まとめました。種類別セグメントは、経口、注射剤等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。化学療法による骨髄抑制治療の世界市場概観、企業動向、企業別化学療法による骨髄抑制治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・化学療法による骨髄抑制治療の市場概観
・化学療法による骨髄抑制治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・化学療法による骨髄抑制治療の企業別販売動向、市場シェア、市場集中度、競争動向
・化学療法による骨髄抑制治療の世界市場規模
・化学療法による骨髄抑制治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・化学療法による骨髄抑制治療のアメリカ市場規模推移
・化学療法による骨髄抑制治療のカナダ市場規模推移
・化学療法による骨髄抑制治療のメキシコ市場規模推移
・化学療法による骨髄抑制治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・化学療法による骨髄抑制治療のドイツ市場規模推移
・化学療法による骨髄抑制治療のイギリス市場規模推移
・化学療法による骨髄抑制治療のロシア市場規模推移
・化学療法による骨髄抑制治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・化学療法による骨髄抑制治療の日本市場規模推移
・化学療法による骨髄抑制治療の中国市場規模推移
・化学療法による骨髄抑制治療の韓国市場規模推移
・化学療法による骨髄抑制治療のインド市場規模推移
・化学療法による骨髄抑制治療の東南アジア市場規模推移
・化学療法による骨髄抑制治療の南米市場分析（ブラジル、アルゼンチン等）
・化学療法による骨髄抑制治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・化学療法による骨髄抑制治療の種類別分析/販売量、売上、市場シェア（経口、注射剤）
・化学療法による骨髄抑制治療の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局）
・化学療法による骨髄抑制治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・化学療法による骨髄抑制治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The global Chemotherapy-Induced Myelosuppression Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chemotherapy-Induced Myelosuppression Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Chemotherapy-Induced Myelosuppression Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chemotherapy-Induced Myelosuppression Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Novartis
Teva Pharmaceutical
Mylan
Amgen
Johnson & Johnson
Partner Therapeutics
Mission Pharmacal
Myelo Therapeutics
Dova Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral
Injectable

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

【レポートの目次】

Table of Contents

1 Chemotherapy-Induced Myelosuppression Treatment Market Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Myelosuppression Treatment
1.2 Classification of Chemotherapy-Induced Myelosuppression Treatment by Types
1.2.1 Global Chemotherapy-Induced Myelosuppression Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Types in 2018
1.2.3 Oral
1.2.4 Injectable
1.3 Global Chemotherapy-Induced Myelosuppression Treatment Market by Application
1.3.1 Global Chemotherapy-Induced Myelosuppression Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Chemotherapy-Induced Myelosuppression Treatment Market by Regions
1.4.1 Global Chemotherapy-Induced Myelosuppression Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Chemotherapy-Induced Myelosuppression Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chemotherapy-Induced Myelosuppression Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chemotherapy-Induced Myelosuppression Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Chemotherapy-Induced Myelosuppression Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chemotherapy-Induced Myelosuppression Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Chemotherapy-Induced Myelosuppression Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Chemotherapy-Induced Myelosuppression Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Chemotherapy-Induced Myelosuppression Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva Pharmaceutical
2.3.1 Business Overview
2.3.2 Chemotherapy-Induced Myelosuppression Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceutical Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Chemotherapy-Induced Myelosuppression Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mylan Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Amgen
2.5.1 Business Overview
2.5.2 Chemotherapy-Induced Myelosuppression Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amgen Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Chemotherapy-Induced Myelosuppression Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Partner Therapeutics
2.7.1 Business Overview
2.7.2 Chemotherapy-Induced Myelosuppression Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Partner Therapeutics Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Mission Pharmacal
2.8.1 Business Overview
2.8.2 Chemotherapy-Induced Myelosuppression Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mission Pharmacal Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Myelo Therapeutics
2.9.1 Business Overview
2.9.2 Chemotherapy-Induced Myelosuppression Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Myelo Therapeutics Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Dova Pharmaceuticals
2.10.1 Business Overview
2.10.2 Chemotherapy-Induced Myelosuppression Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Dova Pharmaceuticals Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Chemotherapy-Induced Myelosuppression Treatment Market Competition, by Players
3.1 Global Chemotherapy-Induced Myelosuppression Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Chemotherapy-Induced Myelosuppression Treatment Players Market Share
3.2.2 Top 10 Chemotherapy-Induced Myelosuppression Treatment Players Market Share
3.3 Market Competition Trend
4 Global Chemotherapy-Induced Myelosuppression Treatment Market Size by Regions
4.1 Global Chemotherapy-Induced Myelosuppression Treatment Revenue and Market Share by Regions
4.2 North America Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
5 North America Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries
5.1 North America Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
5.2 USA Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
6 Europe Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries
6.1 Europe Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
6.2 Germany Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
6.4 France Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries
7.1 Asia-Pacific Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
7.2 China Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
7.5 India Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
8 South America Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries
8.1 South America Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
8.2 Brazil Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Chemotherapy-Induced Myelosuppression Treatment by Countries
9.1 Middle East and Africa Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
10 Global Chemotherapy-Induced Myelosuppression Treatment Market Segment by Type
10.1 Global Chemotherapy-Induced Myelosuppression Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Chemotherapy-Induced Myelosuppression Treatment Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2014-2024)
10.4 Injectable Revenue Growth Rate (2014-2024)
11 Global Chemotherapy-Induced Myelosuppression Treatment Market Segment by Application
11.1 Global Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Application (2014-2019)
11.2 Chemotherapy-Induced Myelosuppression Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Chemotherapy-Induced Myelosuppression Treatment Market Size Forecast (2019-2024)
12.1 Global Chemotherapy-Induced Myelosuppression Treatment Market Size Forecast (2019-2024)
12.2 Global Chemotherapy-Induced Myelosuppression Treatment Market Forecast by Regions (2019-2024)
12.3 North America Chemotherapy-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Chemotherapy-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Chemotherapy-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
12.6 South America Chemotherapy-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Chemotherapy-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Chemotherapy-Induced Myelosuppression Treatment Picture
Table Product Specifications of Chemotherapy-Induced Myelosuppression Treatment
Table Global Chemotherapy-Induced Myelosuppression Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Types in 2018
Figure Oral Picture
Figure Injectable Picture
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) by Application (2014-2024)
Figure Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Chemotherapy-Induced Myelosuppression Treatment Type and Applications
Table Pfizer Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Chemotherapy-Induced Myelosuppression Treatment Type and Applications
Table Novartis Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Chemotherapy-Induced Myelosuppression Treatment Type and Applications
Table Teva Pharmaceutical Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Chemotherapy-Induced Myelosuppression Treatment Type and Applications
Table Mylan Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Chemotherapy-Induced Myelosuppression Treatment Type and Applications
Table Amgen Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Chemotherapy-Induced Myelosuppression Treatment Type and Applications
Table Johnson & Johnson Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Partner Therapeutics Basic Information, Manufacturing Base and Competitors
Table Partner Therapeutics Chemotherapy-Induced Myelosuppression Treatment Type and Applications
Table Partner Therapeutics Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Mission Pharmacal Basic Information, Manufacturing Base and Competitors
Table Mission Pharmacal Chemotherapy-Induced Myelosuppression Treatment Type and Applications
Table Mission Pharmacal Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Myelo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Myelo Therapeutics Chemotherapy-Induced Myelosuppression Treatment Type and Applications
Table Myelo Therapeutics Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Dova Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Dova Pharmaceuticals Chemotherapy-Induced Myelosuppression Treatment Type and Applications
Table Dova Pharmaceuticals Chemotherapy-Induced Myelosuppression Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue Share by Players (2014-2019)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue Share by Players in 2017
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share in 2018
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Regions in 2018
Figure North America Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure South America Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table North America Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
Table North America Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries in 2018
Figure USA Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table Europe Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries in 2018
Figure Germany Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure UK Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure France Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries in 2018
Figure China Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure India Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table South America Chemotherapy-Induced Myelosuppression Treatment Revenue by Countries (2014-2019)
Table South America Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries in 2018
Figure Brazil Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Chemotherapy-Induced Myelosuppression Treatment Revenue and Growth Rate (2014-2019)
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue Share by Type (2014-2019)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue Share by Type (2014-2019)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue Share by Type in 2019
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue Forecast by Type (2019-2024)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Market Share Forecast by Type (2019-2024)
Figure Global Oral Revenue Growth Rate (2014-2019)
Figure Global Injectable Revenue Growth Rate (2014-2019)
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue by Application (2014-2019)
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue Share by Application (2014-2019)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue Share by Application (2014-2019)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue Share by Application in 2019
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue Forecast by Application (2019-2024)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Chemotherapy-Induced Myelosuppression Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Chemotherapy-Induced Myelosuppression Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Chemotherapy-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
Figure Europe Chemotherapy-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Chemotherapy-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
Figure South America Chemotherapy-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Chemotherapy-Induced Myelosuppression Treatment Revenue Market Forecast (2019-2024)


【掲載企業】

Pfizer、Novartis、Teva Pharmaceutical、Mylan、Amgen、Johnson & Johnson、Partner Therapeutics、Mission Pharmacal、Myelo Therapeutics、Dova Pharmaceuticals、

★調査レポート[化学療法による骨髄抑制治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102889)販売に関する免責事項を必ずご確認ください。
★調査レポート[化学療法による骨髄抑制治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 放射線誘発骨髄抑制治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103354 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、放射線誘発骨髄抑制治療の世界市場について調べ、まとめました。種類別セグメントは、成長因子、エリスロポエチン刺激剤、血栓形成剤、鉄補給、その他等、用途別セグメントは、貧血、好中球減少症、血小板減少症、その他等に区分しました。放射線誘発骨髄抑制治療の世界市場概観、企業動向、企業別放射線誘発骨髄抑制治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・放射線誘発骨髄抑制治療の市場概観 ・放射線誘発骨髄抑制治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・放射線誘発骨髄抑制治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・放射線誘発骨髄抑制治療の世界市場規模 ・放射線誘発骨髄抑制治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・放射線誘発骨髄抑制治療のアメリカ市場規模推移 ・放射線誘発骨髄抑制治療のカナダ市場規模推移 ・放射線誘発骨髄抑制治療のメキシコ市場規模推移 ・放射線誘発骨髄抑制治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Radiation-Induced Myelosuppression Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Radiation-Induced Myelosuppression Treatment. Europe also play important roles in...
  • 人工多能性幹細胞（iPSC）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103577 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、人工多能性幹細胞（iPSC）の世界市場について調べ、まとめました。種類別セグメントは、ヒトiPSC、マウスiPSC等、用途別セグメントは、学術研究、医薬品の開発と発見、毒性スクリーニング、再生医学等に区分しました。人工多能性幹細胞（iPSC）の世界市場概観、企業動向、企業別人工多能性幹細胞（iPSC）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・人工多能性幹細胞（iPSC）の市場概観 ・人工多能性幹細胞（iPSC）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・人工多能性幹細胞（iPSC）の企業別販売動向、市場シェア、市場集中度、競争動向 ・人工多能性幹細胞（iPSC）の世界市場規模 ・人工多能性幹細胞（iPSC）の北米市場分析（アメリカ、カナダ、メキシコ等） ・人工多能性幹細胞（iPSC）のアメリカ市場規模推移 ・人工多能性幹細胞（iPSC）のカナダ市場規模推移 ・人工多能性幹細胞（iPSC）のメキシコ市場規模推移 ・人工多能性幹細胞（iPSC）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The global Induced Pluripotent Stem Cells (iPSCs) market is valued at 74 million USD in 2018 and is expected to reach 114.9 million USD by the end of 2024, growing at a CAGR of 11.7% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Induced Pluripotent Stem Cells (iPSCs). Europe also...
  • 化学療法シリンジポンプの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100061 / GlobalInfoResearch / 2019年10月9日 / 本調査レポートは、化学療法シリンジポンプの世界市場について調べ、まとめました。種類別セグメントは、シングルチャンネル、マルチチャンネル等、用途別セグメントは、がん、腫瘍、その他等に区分しました。化学療法シリンジポンプの世界市場概観、メーカー動向、メーカー別化学療法シリンジポンプシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・化学療法シリンジポンプの市場概観 ・化学療法シリンジポンプの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・化学療法シリンジポンプの企業別販売動向、市場シェア、市場集中度、競争動向 ・化学療法シリンジポンプの世界市場規模 ・化学療法シリンジポンプの北米市場分析（アメリカ、カナダ、メキシコ等） ・化学療法シリンジポンプのアメリカ市場規模推移 ・化学療法シリンジポンプのカナダ市場規模推移 ・化学療法シリンジポンプのメキシコ市場規模推移 ・化学療法シリンジポンプのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Chemotherapy is short for chemotherapeutic therapy, which uses chemotherapeutic drugs to kill cancer cells for therapeutic purposes. Scope of the Report: The worldwide market for Chemotherapy Syringe Pump is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Chemotherapy Syringe Pump in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and...
  • 副鼻腔がん治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100514 / GlobalInfoResearch / 2019年9月4日 / 本調査レポートは、副鼻腔がん治療の世界市場について調べ、まとめました。種類別セグメントは、手術、放射線療法、化学療法等、用途別セグメントは、病院と診療所、がん治療研究センター、研究所、その他等に区分しました。副鼻腔がん治療の世界市場概観、企業動向、企業別副鼻腔がん治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・副鼻腔がん治療の市場概観 ・副鼻腔がん治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・副鼻腔がん治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・副鼻腔がん治療の世界市場規模 ・副鼻腔がん治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・副鼻腔がん治療のアメリカ市場規模推移 ・副鼻腔がん治療のカナダ市場規模推移 ・副鼻腔がん治療のメキシコ市場規模推移 ・副鼻腔がん治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...If cancer is in the ethmoid sinus, treatment may include the following: Surgery followed by radiation therapy. A clinical trial of combination chemotherapy before surgery or radiation therapy. A clinical trial of combination chemotherapy after surgery or other cancer treatment. Scope of the Report: The global Paranasal Sinus Cancer Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India...
  • 自動車表面処理/熱処理の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103059 / GlobalInfoResearch / 2019年9月24日 / 本調査レポートは、自動車表面処理/熱処理の世界市場について調べ、まとめました。種類別セグメントは、化学処理、熱処理、その他等、用途別セグメントは、乗用車、商用車等に区分しました。自動車表面処理/熱処理の世界市場概観、企業動向、企業別自動車表面処理/熱処理シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・自動車表面処理/熱処理の市場概観 ・自動車表面処理/熱処理の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・自動車表面処理/熱処理の企業別販売動向、市場シェア、市場集中度、競争動向 ・自動車表面処理/熱処理の世界市場規模 ・自動車表面処理/熱処理の北米市場分析（アメリカ、カナダ、メキシコ等） ・自動車表面処理/熱処理のアメリカ市場規模推移 ・自動車表面処理/熱処理のカナダ市場規模推移 ・自動車表面処理/熱処理のメキシコ市場規模推移 ・自動車表面処理/熱処理のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Heat treatment and surface modification are the key technologies available today, to enhance the effective use of materials, to achieve the desired properties of the components used in the automotive industries, to save energy and conserve natural resources. Scope of the Report: Heat treatment is a type of surface treatment that includes hardening and thermal diffusion. The global Automotive Surface Treatment/Heat Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in...

    • ◆H&Iグローバルリサーチのお客様（例）◆